Short answer · Medically reviewed summary · Last updated: 2026-04-06
Bell's palsy is a relatively common condition, with an estimated annual incidence of approximately 15 to 30 cases per 100,000 people in the general population. Epidemiological Overview While Bell's palsy is not classified as a "rare disease" by most regulatory definitions, it remains a significant focus for the Bell's palsy community at DiseaseMaps.org, where 302 individuals have shared their unique clinical journeys. The lifetime risk of developing Bell's palsy is estimated at about 1 in 60 to 1 in 70 individuals.
Bell's palsy is a relatively common condition, with an estimated annual incidence of approximately 15 to 30 cases per 100,000 people in the general population.
While Bell's palsy is not classified as a "rare disease" by most regulatory definitions, it remains a significant focus for the Bell's palsy community at DiseaseMaps.org, where 302 individuals have shared their unique clinical journeys. The lifetime risk of developing Bell's palsy is estimated at about 1 in 60 to 1 in 70 individuals. Because many mild cases may resolve spontaneously without medical intervention, these figures likely represent an underestimation of the true prevalence.
Bell's palsy affects males and females with roughly equal frequency, though some data suggests a slightly higher incidence in pregnant women during the third trimester or the immediate postpartum period. While the condition can occur at any age, it is most frequently diagnosed in adults between the ages of 15 and 60. Pediatric cases do occur but are statistically less common. There is no definitive evidence of significant ethnic or geographic clustering, though some studies suggest that individuals with diabetes or those who are immunocompromised may be at a higher risk of developing the facial paralysis associated with Bell's palsy.
Accurate epidemiological tracking is hindered by the fact that Bell's palsy is a diagnosis of exclusion. Because patients often present with "stroke-like" symptoms, clinicians must carefully rule out other neurological conditions, such as Lyme disease, tumors, or shingles (Herpes zoster oticus). This diagnostic complexity means that regional data can vary based on the stringency of clinical reporting. Our community at DiseaseMaps.org provides invaluable real-world data, highlighting that while clinical literature focuses on acute onset, many patients navigate long-term challenges related to synkinesis and ocular health that are not always captured in standard incidence reports.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.